Globus Medical, Inc.
GMED
$58.17
-$0.08-0.14%
NYSE
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -9.00% | 5.05% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -9.00% | 5.05% | |||
| Cost of Revenue | -9.61% | 3.02% | |||
| Gross Profit | -8.71% | 6.07% | |||
| SG&A Expenses | -4.18% | 5.37% | |||
| Depreciation & Amortization | -3.71% | -0.55% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.15% | 3.42% | |||
| Operating Income | -21.22% | 12.64% | |||
| Income Before Tax | 320.27% | -56.75% | |||
| Income Tax Expenses | 1,634.60% | -135.37% | |||
| Earnings from Continuing Operations | 184.71% | -48.87% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 184.71% | -48.87% | |||
| EBIT | -21.22% | 12.64% | |||
| EBITDA | -14.79% | 8.60% | |||
| EPS Basic | 184.58% | -49.27% | |||
| Normalized Basic EPS | 18.02% | -26.62% | |||
| EPS Diluted | 184.21% | -50.00% | |||
| Normalized Diluted EPS | 17.98% | -26.88% | |||
| Average Basic Shares Outstanding | 0.02% | 0.82% | |||
| Average Diluted Shares Outstanding | 0.05% | 1.19% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||